Equities

Soho Global Health Tbk PT

SOHO:JKT

Soho Global Health Tbk PT

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (IDR)690.00
  • Today's Change-5.00 / -0.72%
  • Shares traded27.60k
  • 1 Year change+22.12%
  • Beta-0.8501
Data delayed at least 10 minutes, as of Nov 08 2024 09:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in IDRIncome statement in IDRView more

Year on year Soho Global Health Tbk PT grew revenues 12.45% from 7.29tn to 8.20tn while net income improved 4.10% from 356.73bn to 371.34bn.
Gross margin15.48%
Net profit margin4.59%
Operating margin5.63%
Return on assets8.94%
Return on equity17.23%
Return on investment16.19%
More ▼

Cash flow in IDRView more

In 2023, cash reserves at Soho Global Health Tbk PT fell by 438.37bn. However, the company earned 211.13bn from its operations for a Cash Flow Margin of 2.58%. In addition the company used 232.90bn on investing activities and also paid 416.59bn in financing cash flows.
Cash flow per share40.24
Price/Cash flow per share17.15
Book value per share204.34
Tangible book value per share203.02
More ▼

Balance sheet in IDRView more

Soho Global Health Tbk PT uses little debt in its capital structure as supported by a debt to capital ratio of 0.47%.
Current ratio1.85
Quick ratio1.25
Total debt/total equity0.0047
Total debt/total capital0.0047
More ▼

Growth rates in IDR

Year on year, growth in dividends per share fell -49.15% while earnings per share excluding extraordinary items rose 4.10%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)34.40%
EPS growth(5 years)33.50
EPS (TTM) vs
TTM 1 year ago
30.62
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.